skip to Main Content

September 2, 2015

Codexis to Present at Rodman & Renshaw Global Investment Conference

REDWOOD CITY, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces that management will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Wednesday, September 9, 2015, at 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference is being held at the St. Regis Hotel in New York City.

A live webcast and replay of the presentation will be available on the Investors section of the company’s website, http://ir.codexis.com/.

About Codexis, Inc.

Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.

CONTACT:
Investors
LHA

Jody Cain, 310 691 7100
jcain@lhai.com

That’s Nice, LLC
Guy Tiene, +1 212 366 4455
Guy@thatsnice.com


Codexis

Codexis, Inc.

Back To Top
Close search
Search